 Xiyuan Bai
Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 12 | 2023 | 266 | 4.100 |
Why?
| | Tuberculosis | 11 | 2023 | 240 | 3.500 |
Why?
| | Interleukins | 8 | 2019 | 239 | 2.390 |
Why?
| | alpha 1-Antitrypsin | 4 | 2022 | 109 | 2.180 |
Why?
| | Macrophages, Alveolar | 5 | 2019 | 353 | 1.890 |
Why?
| | alpha 1-Antitrypsin Deficiency | 4 | 2023 | 77 | 1.780 |
Why?
| | Macrophages | 10 | 2022 | 1296 | 1.320 |
Why?
| | Mycobacterium avium Complex | 4 | 2021 | 92 | 1.190 |
Why?
| | Mycobacterium avium-intracellulare Infection | 2 | 2019 | 62 | 1.020 |
Why?
| | NF-kappa B | 6 | 2022 | 634 | 0.870 |
Why?
| | Nicotine | 3 | 2023 | 262 | 0.860 |
Why?
| | Cigarette Smoking | 1 | 2023 | 79 | 0.840 |
Why?
| | Enoxaparin | 1 | 2022 | 51 | 0.810 |
Why?
| | Receptors, Glucocorticoid | 1 | 2022 | 132 | 0.790 |
Why?
| | Apoptosis | 5 | 2020 | 2427 | 0.750 |
Why?
| | Mycobacterium Infections, Nontuberculous | 8 | 2021 | 335 | 0.670 |
Why?
| | Interferon-gamma | 6 | 2015 | 732 | 0.600 |
Why?
| | T-Lymphocytes, Regulatory | 4 | 2023 | 355 | 0.570 |
Why?
| | Testis | 2 | 2009 | 143 | 0.540 |
Why?
| | Curcumin | 1 | 2016 | 30 | 0.540 |
Why?
| | Autophagy | 4 | 2021 | 309 | 0.480 |
Why?
| | Nontuberculous Mycobacteria | 5 | 2018 | 207 | 0.470 |
Why?
| | Microbial Viability | 2 | 2013 | 81 | 0.460 |
Why?
| | Models, Biological | 1 | 2020 | 1695 | 0.450 |
Why?
| | Chemokine CXCL10 | 2 | 2010 | 37 | 0.440 |
Why?
| | Smoking | 5 | 2020 | 1464 | 0.410 |
Why?
| | Tuberculosis, Pulmonary | 3 | 2015 | 112 | 0.400 |
Why?
| | Monocytes | 2 | 2011 | 507 | 0.400 |
Why?
| | Casein Kinase II | 2 | 2009 | 21 | 0.400 |
Why?
| | Cell Line | 6 | 2017 | 2669 | 0.390 |
Why?
| | Chemokine CXCL9 | 1 | 2010 | 22 | 0.380 |
Why?
| | Serine Endopeptidases | 2 | 2022 | 104 | 0.380 |
Why?
| | Respiratory System | 1 | 2011 | 141 | 0.370 |
Why?
| | Lung Diseases | 4 | 2021 | 698 | 0.360 |
Why?
| | Epithelial Cells | 3 | 2018 | 940 | 0.350 |
Why?
| | Humans | 35 | 2023 | 116801 | 0.350 |
Why?
| | Anti-Inflammatory Agents | 2 | 2022 | 456 | 0.310 |
Why?
| | Disease Susceptibility | 5 | 2018 | 327 | 0.290 |
Why?
| | Phosphoproteins | 1 | 2009 | 302 | 0.290 |
Why?
| | Dendritic Cells | 2 | 2021 | 442 | 0.290 |
Why?
| | Smoke | 2 | 2020 | 137 | 0.290 |
Why?
| | Interleukin-8 | 2 | 2022 | 235 | 0.270 |
Why?
| | Protein Subunits | 3 | 2017 | 208 | 0.270 |
Why?
| | Cells, Cultured | 6 | 2019 | 3962 | 0.240 |
Why?
| | Lipopolysaccharides | 2 | 2022 | 828 | 0.240 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2015 | 1138 | 0.230 |
Why?
| | Serine Proteinase Inhibitors | 2 | 2022 | 34 | 0.230 |
Why?
| | Cytokines | 4 | 2019 | 1855 | 0.230 |
Why?
| | Nuclear Proteins | 2 | 2009 | 591 | 0.230 |
Why?
| | Molecular Epidemiology | 1 | 2023 | 69 | 0.220 |
Why?
| | Th1 Cells | 1 | 2004 | 131 | 0.220 |
Why?
| | Angiopoietins | 1 | 2022 | 14 | 0.220 |
Why?
| | Th2 Cells | 1 | 2004 | 164 | 0.220 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 59 | 0.220 |
Why?
| | Animals | 17 | 2023 | 32699 | 0.220 |
Why?
| | Immunity, Innate | 3 | 2018 | 741 | 0.210 |
Why?
| | Microtubule-Associated Proteins | 1 | 2003 | 184 | 0.210 |
Why?
| | Heparin | 1 | 2023 | 227 | 0.210 |
Why?
| | Autophagosomes | 2 | 2021 | 21 | 0.200 |
Why?
| | Adipokines | 2 | 2019 | 43 | 0.200 |
Why?
| | Mice | 11 | 2023 | 15289 | 0.200 |
Why?
| | Virus Internalization | 1 | 2020 | 41 | 0.190 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2003 | 400 | 0.190 |
Why?
| | Leukocyte Elastase | 1 | 2020 | 69 | 0.190 |
Why?
| | Antithrombins | 1 | 2020 | 50 | 0.190 |
Why?
| | Extracellular Traps | 1 | 2020 | 40 | 0.190 |
Why?
| | Radiation Tolerance | 1 | 2021 | 98 | 0.180 |
Why?
| | Orotate Phosphoribosyltransferase | 1 | 1999 | 2 | 0.180 |
Why?
| | Kluyveromyces | 1 | 1999 | 4 | 0.180 |
Why?
| | Genes, Fungal | 1 | 1999 | 47 | 0.180 |
Why?
| | HEK293 Cells | 1 | 2022 | 624 | 0.180 |
Why?
| | Phagosomes | 1 | 2019 | 43 | 0.170 |
Why?
| | Adipose Tissue, White | 1 | 2019 | 35 | 0.170 |
Why?
| | Vitamin A | 1 | 2019 | 53 | 0.170 |
Why?
| | Transcription Factor RelA | 1 | 2019 | 79 | 0.170 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 155 | 0.170 |
Why?
| | Lung | 6 | 2021 | 3584 | 0.170 |
Why?
| | Mycobacterium | 2 | 2010 | 103 | 0.160 |
Why?
| | Leishmania infantum | 1 | 2018 | 4 | 0.160 |
Why?
| | Leishmaniasis, Visceral | 1 | 2018 | 5 | 0.160 |
Why?
| | Macrophage Activation | 1 | 2019 | 164 | 0.160 |
Why?
| | Emphysema | 1 | 2019 | 122 | 0.160 |
Why?
| | Bronchiectasis | 1 | 2019 | 105 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 963 | 0.160 |
Why?
| | Protective Factors | 1 | 2018 | 89 | 0.160 |
Why?
| | Adipocytes | 1 | 2019 | 193 | 0.150 |
Why?
| | Anti-Bacterial Agents | 5 | 2015 | 1497 | 0.150 |
Why?
| | Interleukin-12 | 2 | 2011 | 110 | 0.150 |
Why?
| | Nicotinic Antagonists | 1 | 2017 | 19 | 0.150 |
Why?
| | Interleukin-4 | 3 | 2009 | 216 | 0.150 |
Why?
| | Acute Lung Injury | 1 | 2020 | 276 | 0.150 |
Why?
| | Gene Expression | 3 | 2011 | 1468 | 0.150 |
Why?
| | Mice, Transgenic | 3 | 2019 | 1992 | 0.150 |
Why?
| | Immunotherapy | 1 | 2021 | 491 | 0.150 |
Why?
| | Virulence Factors | 1 | 2018 | 142 | 0.150 |
Why?
| | Adaptive Immunity | 2 | 2015 | 160 | 0.140 |
Why?
| | Spermatids | 2 | 2009 | 18 | 0.140 |
Why?
| | Two-Hybrid System Techniques | 2 | 2009 | 57 | 0.140 |
Why?
| | Transforming Growth Factor beta | 2 | 2013 | 458 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 667 | 0.140 |
Why?
| | Protective Agents | 1 | 2016 | 41 | 0.140 |
Why?
| | Models, Immunological | 1 | 2016 | 92 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 470 | 0.130 |
Why?
| | Respiratory Mucosa | 1 | 2018 | 252 | 0.130 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily B | 1 | 2015 | 10 | 0.130 |
Why?
| | Antigens, Ly | 1 | 2015 | 45 | 0.130 |
Why?
| | RNA Splice Sites | 1 | 2015 | 34 | 0.130 |
Why?
| | Receptors, Nicotinic | 1 | 2017 | 270 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2020 | 648 | 0.130 |
Why?
| | Bacterial Load | 1 | 2015 | 61 | 0.130 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2015 | 41 | 0.130 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2015 | 78 | 0.120 |
Why?
| | Lymph Nodes | 2 | 2015 | 444 | 0.120 |
Why?
| | Transgenes | 1 | 2015 | 173 | 0.120 |
Why?
| | Biofilms | 2 | 2014 | 229 | 0.120 |
Why?
| | Cytoplasm | 1 | 2015 | 268 | 0.120 |
Why?
| | Mycobacterium Infections | 3 | 2010 | 61 | 0.120 |
Why?
| | Virulence | 1 | 2015 | 237 | 0.120 |
Why?
| | Latent Tuberculosis | 1 | 2015 | 68 | 0.120 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1651 | 0.120 |
Why?
| | Respiratory Tract Infections | 1 | 2018 | 329 | 0.120 |
Why?
| | Biomimetic Materials | 1 | 2014 | 65 | 0.120 |
Why?
| | Acanthamoeba | 1 | 2013 | 5 | 0.110 |
Why?
| | Mycobacterium avium | 1 | 2013 | 22 | 0.110 |
Why?
| | Cell Movement | 1 | 2017 | 879 | 0.110 |
Why?
| | Intracellular Space | 1 | 2013 | 68 | 0.110 |
Why?
| | Interleukin-18 | 2 | 2011 | 225 | 0.110 |
Why?
| | Caspase Inhibitors | 1 | 2013 | 79 | 0.110 |
Why?
| | Transfection | 1 | 2015 | 876 | 0.110 |
Why?
| | Water Supply | 1 | 2013 | 71 | 0.110 |
Why?
| | Sulfones | 1 | 2013 | 97 | 0.110 |
Why?
| | Water Microbiology | 1 | 2013 | 77 | 0.110 |
Why?
| | Nitriles | 1 | 2013 | 155 | 0.110 |
Why?
| | Adenoviridae | 1 | 2013 | 189 | 0.110 |
Why?
| | Pandemics | 1 | 2020 | 1334 | 0.110 |
Why?
| | Caspase 3 | 1 | 2013 | 237 | 0.100 |
Why?
| | Lipid Metabolism | 1 | 2015 | 468 | 0.100 |
Why?
| | Amikacin | 1 | 2011 | 20 | 0.100 |
Why?
| | Lipids | 1 | 2015 | 584 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2015 | 394 | 0.100 |
Why?
| | Granuloma | 1 | 2011 | 84 | 0.100 |
Why?
| | Blotting, Northern | 1 | 2010 | 192 | 0.100 |
Why?
| | RNA, Small Interfering | 2 | 2010 | 557 | 0.100 |
Why?
| | Case-Control Studies | 3 | 2013 | 3120 | 0.090 |
Why?
| | Blotting, Western | 2 | 2010 | 1168 | 0.090 |
Why?
| | In Situ Nick-End Labeling | 1 | 2010 | 123 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1185 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 693 | 0.090 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 261 | 0.090 |
Why?
| | Base Sequence | 3 | 2003 | 2125 | 0.090 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 977 | 0.080 |
Why?
| | Transcriptional Activation | 1 | 2010 | 342 | 0.080 |
Why?
| | Mycoplasma pneumoniae | 1 | 2008 | 33 | 0.080 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2008 | 33 | 0.080 |
Why?
| | Up-Regulation | 1 | 2010 | 834 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2003 | 2034 | 0.070 |
Why?
| | Interleukin-1beta | 1 | 2009 | 368 | 0.070 |
Why?
| | Mycobacteriaceae | 1 | 2007 | 21 | 0.070 |
Why?
| | Bronchi | 1 | 2008 | 240 | 0.070 |
Why?
| | Molecular Sequence Data | 2 | 2003 | 2820 | 0.070 |
Why?
| | Obesity | 1 | 2019 | 2653 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4830 | 0.070 |
Why?
| | In Situ Hybridization | 2 | 2003 | 301 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2014 | 3626 | 0.070 |
Why?
| | Interleukin-10 | 2 | 2008 | 301 | 0.070 |
Why?
| | Phosphorylation | 1 | 2009 | 1590 | 0.060 |
Why?
| | Cell Membrane | 1 | 2008 | 689 | 0.060 |
Why?
| | Mutation | 1 | 2015 | 3408 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2010 | 1151 | 0.060 |
Why?
| | Chemokines, CXC | 1 | 2004 | 59 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2009 | 877 | 0.060 |
Why?
| | t-Complex Genome Region | 1 | 2003 | 3 | 0.060 |
Why?
| | Testicular Hormones | 1 | 2003 | 9 | 0.060 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2003 | 11 | 0.060 |
Why?
| | Dyneins | 1 | 2003 | 30 | 0.060 |
Why?
| | Spermatogenesis | 1 | 2003 | 53 | 0.060 |
Why?
| | Spermatozoa | 1 | 2003 | 91 | 0.050 |
Why?
| | Sequence Alignment | 1 | 2003 | 333 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 328 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2010 | 1732 | 0.050 |
Why?
| | Phenotype | 3 | 2021 | 2890 | 0.050 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2003 | 145 | 0.050 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2021 | 18 | 0.050 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2021 | 40 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 70 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.050 |
Why?
| | Lymphocyte Depletion | 1 | 2021 | 116 | 0.050 |
Why?
| | Biological Assay | 1 | 2021 | 120 | 0.050 |
Why?
| | Lysosomes | 1 | 2021 | 135 | 0.050 |
Why?
| | Tumor Burden | 1 | 2021 | 272 | 0.050 |
Why?
| | Male | 7 | 2019 | 56636 | 0.040 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 2019 | 9 | 0.040 |
Why?
| | Retinal Dehydrogenase | 1 | 2019 | 40 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2019 | 107 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 804 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2004 | 767 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2008 | 2405 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 1999 | 525 | 0.040 |
Why?
| | Hyperinsulinism | 1 | 2019 | 106 | 0.040 |
Why?
| | Leptin | 1 | 2019 | 225 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 449 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1156 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2021 | 377 | 0.040 |
Why?
| | Signal Transduction | 1 | 2010 | 4605 | 0.040 |
Why?
| | Middle Aged | 3 | 2012 | 27140 | 0.040 |
Why?
| | Models, Animal | 1 | 2018 | 347 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1340 | 0.030 |
Why?
| | Female | 6 | 2012 | 60542 | 0.030 |
Why?
| | Cathelicidins | 1 | 2015 | 39 | 0.030 |
Why?
| | Energy-Generating Resources | 1 | 2015 | 8 | 0.030 |
Why?
| | Metabolic Syndrome | 1 | 2019 | 381 | 0.030 |
Why?
| | United States | 1 | 2011 | 12337 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 899 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2647 | 0.030 |
Why?
| | Biomass | 1 | 2015 | 128 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 120 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 154 | 0.030 |
Why?
| | Tobacco Products | 1 | 2015 | 66 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2015 | 300 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 2808 | 0.030 |
Why?
| | Fibrillins | 1 | 2013 | 8 | 0.030 |
Why?
| | Hartmannella | 1 | 2013 | 2 | 0.030 |
Why?
| | Marfan Syndrome | 1 | 2013 | 41 | 0.030 |
Why?
| | Aged | 1 | 2011 | 19362 | 0.030 |
Why?
| | Surface Properties | 1 | 2014 | 388 | 0.030 |
Why?
| | Funnel Chest | 1 | 2012 | 20 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2013 | 204 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2013 | 130 | 0.030 |
Why?
| | Tobacco Smoke Pollution | 1 | 2015 | 231 | 0.030 |
Why?
| | Drinking Water | 1 | 2013 | 68 | 0.030 |
Why?
| | Glutathione Peroxidase | 1 | 2010 | 54 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 3540 | 0.020 |
Why?
| | Catalase | 1 | 2010 | 120 | 0.020 |
Why?
| | Free Radical Scavengers | 1 | 2010 | 88 | 0.020 |
Why?
| | Scoliosis | 1 | 2012 | 185 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2010 | 171 | 0.020 |
Why?
| | Interferon Regulatory Factor-1 | 1 | 2009 | 12 | 0.020 |
Why?
| | STAT6 Transcription Factor | 1 | 2009 | 22 | 0.020 |
Why?
| | Acetylcysteine | 1 | 2010 | 147 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2021 | 12740 | 0.020 |
Why?
| | Arginase | 1 | 2009 | 27 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 279 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2009 | 161 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2523 | 0.020 |
Why?
| | Prevalence | 1 | 2015 | 2301 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2012 | 582 | 0.020 |
Why?
| | Environment | 1 | 2010 | 342 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 797 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2010 | 337 | 0.020 |
Why?
| | Hospitals | 1 | 2013 | 594 | 0.020 |
Why?
| | Arginine | 1 | 2009 | 239 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2008 | 151 | 0.020 |
Why?
| | Down-Regulation | 1 | 2010 | 605 | 0.020 |
Why?
| | Ecosystem | 1 | 2013 | 545 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2008 | 114 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 158 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 906 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2008 | 276 | 0.020 |
Why?
| | Spleen | 1 | 2008 | 491 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 1893 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2008 | 392 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2010 | 650 | 0.020 |
Why?
| | Body Mass Index | 1 | 2012 | 2058 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1141 | 0.020 |
Why?
| | Chronic Disease | 1 | 2010 | 1611 | 0.010 |
Why?
| | Sperm Head | 1 | 2003 | 3 | 0.010 |
Why?
| | Microscopy, Immunoelectron | 1 | 2003 | 45 | 0.010 |
Why?
| | Meiosis | 1 | 2003 | 61 | 0.010 |
Why?
| | DNA Primers | 1 | 2003 | 526 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1320 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2627 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 8865 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2003 | 997 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2003 | 574 | 0.010 |
Why?
| | Transcription Factors | 1 | 2008 | 1558 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2232 | 0.010 |
Why?
| | Genotype | 1 | 2003 | 1853 | 0.010 |
Why?
| | Adult | 1 | 2019 | 30930 | 0.010 |
Why?
| | Cohort Studies | 1 | 2007 | 5047 | 0.010 |
Why?
| | Asthma | 1 | 2008 | 2157 | 0.010 |
Why?
|
|
Bai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|